Introduction
Interferons (IFNs)1 are polypeptides that regulate a variety of biological effects, the most no-* This work was supported in part by the March of Dimes Foundation grant 1-977. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ' Abbreviations used: DMEM, Dulbecco's modified Eagle's medium; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IFN, interferon; PDB, phorbol-12,1 3-dibutyrate; TPA, 1 2-0-tetradecanoylphorbol 13-acetate. table of which are antigrowth and antiviral activities (Pestka et al., 1987) . Similar to other polypeptide hormones and neurotransmitters, both type I (a and f,) and type 11 (,y) IFNs have specific cell-surface receptors. Among the events that occur within minutes after cells are exposed to IFNs, one of the earliest is the increased expression of several mRNAs (Friedman et al., 1984; Larner et al., 1984 Larner et al., , 1986 Luster et al., 1985; Reich et al., 1987) . Many IFNinduced RNAs have been shown to be activated via increased rates of transcription of their corresponding genes (Friedman et al., 1984; Larner et al., 1984) . An understanding of the molecular mechanisms by which IFN activates gene transcription, which at present are ill defined, should provide insight into the signal transduction pathway(s) used by IFNs.
We have been investigating the gene ISG-54K, whose expression is activated by type I IFNs (Larner et al., 1984; Akai and Larner, 1989) . In human cells, IFN induction of ISG-54K mRNA occurs by a rapid increase in the rates of transcription of the gene. Protein synthesis is not necessary for this response. In some types of cells, such as human diploid fibroblasts and WISH cells, long-term IFN exposure (6-8 h) down regulates the expression of IFN-inducible genes such that reexposure to fresh IFN will not reactivate expression. We call this process desensitization. Inhibitors of protein synthesis prevent IFN-induced desensitization and also enhance IFN-induced ISG-54K rates of transcription.
Recently, acute treatment of cells with phorbol esters has been shown to inhibit transcriptional activation of certain IFN-sensitive genes such as ISG-54K and 2'5' oligo A synthetase (Akai and Larner, 1989; Yan et al., 1989) . However, other IFN-responsive genes are minimally affected by phorbol esters or show enhanced expression (Fan et al., 1988; Akai and Larner, 1989; Erusalimsky et al., 1989; Faltynek et al.; . 12-0-tetradecanoylphorbol 13-acetate (TPA) inhibition of IFN-induced ISG-54K expression is reversed by inhibitors of protein synthesis (Akai and Larner, 1989 
Results
It has been well documented that long-term treatment of cells with phorbol esters makes them protein-kinase-C deficient (Coughlin et al., 1985; Stumpo and Blackshear, 1986) . Conditions were defined in human fibroblasts in which pretreatment with TPA or phorbol-1 2,13-dibutyrate (PDB) rendered the cells insensitive to phorbol ester inhibition of IFN-induced ISG-54K RNA expression (Figure 1 (Akai and Larner, 1989) . We reasoned that the lack of phorbol ester inhibitory activity in protein-kinase-C-depleted cells might also be a transcriptional phenomenon. To test this possibility, a 32P-labeled singlestranded complementary RNA probe that contains the first exon and part of the first intron of the ISG-54K gene was used (Figure 2 ). The 118-bp RNase-resistant fragment represents unprocessed nuclear RNA, because it contains Vol. 1, August 1990 Inhibitors of protein synthesis such as cycloheximide have been shown to enhance IFN-induced ISG-54K rates of transcription as well as prevent long-term incubation with IFN from establishing a desensitized state . During IFN treatment, it is assumed that transcriptional inhibitory factor(s) are synthesized that specifically down regulate the expression of IFN-sensitive genes Akai and Larner, 1989) . The use of protein-kinase-C-depleted cells should make it possible to distinguish whether the mechanism by which phorbol esters and long-term IFN exposure repress IFN-induced ISG-54K expression is the same or different. If the mechanism is the same, then it would be expected that cells desensitized to the effects of phorbol esters would not be desensitized with long-term IFN exposure.
To explore this possibility, the kinetics of transcriptional induction of ISG-54K by IFN were examined in naive and phorbol-ester-desensitized fibroblasts and WISH cells (Figures 3 and  4) . The effects of cycloheximide on IFN-activated ISG-54K expression were also measured. As shown previously in human fibroblasts, maximal transcriptional activation of the ISG-54K gene was observed after 2-4 h of IFN-a incubation (Figure 3) RNAs. Both 32P-labeled ISG-54K antisense probe as described in Figure 2 and 32P-labeled GAPDH probe were hybridized to the same sample of RNA. Relative rates of transcription were determined by densitometric intensities of the 1 1 8-bp fragment corresponding to unprocessed nuclear RNA. Densitometric intensities of this fragment were normalized to the intensity of the GAPDH band (320 bp) to account for experimental errors in RNA yields or during processing of the RNase protection assay. The maximal transcription rate observed (8 h of IFN and cycloheximide in TPA-desensitized cells) was given an arbitrary value of 100. All other rates of ISG-54K transcription were normalized to this value. I, IFN alone; + C, IFN Results presented in these experiments and elsewhere indicate that there are at least two mechanisms that inhibit IFN-activated ISG-54K expression (Larner et al., 1984; Akai and Larner, 1989) . One mechanism occurs after long-term exposure of cells to IFN, and the other occurs in the presence of phorbol esters. These regulatory pathways have characteristics in common. Inhibitors of protein synthesis reverse the actions of both phorbol esters and long-term IFN exposure. Phorbol ester inhibition of ISG-54K expression and long-term IFN-induced desensitization are seen only in certain cell types. The types of cells in which phorbol esters repress IFN-induced ISG-54K expression are the same cells in which IFN-induced desensitization occurs (Akai and Larner, 1989) .
To determine whether each inhibitory mechanism is regulated by the same pathway, we depleted cells of protein kinase C by long-term treatment with phorbol esters, a well-documented method used by numerous investigators (Coughlin et al., 1985; Stumpo and Blackshear, 1986) Data in this report demonstrate a completely opposite result (Figures 3 and 4) . Phorbol-esterdesensitized cells displayed the same kinetics of IFN-induced ISG-54K transcription. In addition, both cell types can be desensitized with long-term exposure to IFN even after being desensitized to the inhibitory actions of phorbol esters. Cycloheximide prevents the desensitization process resulting from prolonged exposure to IFN in both naive cells and cells pretreated with phorbol esters. These results prove that the regulatory mechanisms by which phorbol esters and extended IFN exposure inhibit IFN-induced ISG-54K expression are distinct. The data presented here also argue against the idea that rapid IFN-induced increases in diacylglycerol (Yap et al., 1986a,b) account for the desensitization process that occurs with longterm exposure of cells to IFN (see Figures 3  and 4) .
It remains to be determined whether the DNA sequence elements that regulate phorbol ester and long-term IFN inhibition of ISG-54K expression are the same or different. Preliminary studies with transient transfection assays suggest that the elements that mediate transcriptional repression by phorbol esters and long-term IFN exposure are also distinct and neither appears to involve the IFN-stimulated response element. This is in contrast to the results of Levy et al. (1988) , who suggested that the negative element that turns off ISG-54K expression by longterm exposure to IFN lies within the IFN-stimulated response element, which is present in the promoters of all IFN-inducible genes thus far characterized. However, definitive results that characterize these transcriptional repressors will require the development of permanent cell lines so that actual rates of transcription can be determined to confirm those results seen in transient expression assays. Other approaches, such as DNase I hypersensitivity studies and exonuclease protection assays, are also being pursued to provide more information regarding the definition of the phorbol-esterinhibitory element. When this element is defined, it will then be possible to characterize how phorbol esters inhibit expression of IFN-inducible genes in molecular and biochemical terms, a phenomenon that may or may not be similar to the much better defined actions of phorbol esters to activate the expression of a variety of transcription units (Rabin et al., 1986; Angel et al., 1987; Chui et al., 1987; Fisch et al., 1987; Harrison et al., 1987) . These studies should also 712 contribute to our general understanding of transcriptional repression in eukaryotes (Levine and Manley, 1989) , an area in which considerably less is understood than selective activation of eukaryotic promoters. Methods Cells and cultures Human fibroblasts and WISH cells were grown and passaged in Dulbecco's modified Eagle's medium (DMEM) with 100/% fetal calf serum.
IFNs and reagents
Recombinant IFN-a was a generous gift from Hoffmann LaRoche (Nutley, NJ). TPA was purchased from Sigma (St. Louis, MO). PDB and the a-isomer were obtained from LC Services (Woburn, MA).
Quantitation of RNA using antisense RNA probes RNA was prepared as described by Chirgwin et al. (1979) . RNAs in all experiments were quantitated by RNase protection assays. Antisense RNA probes were synthesized with SP6 RNA polymerase (Bethesda Research Laboratories, Gaithersburg, MD). Plasmid pIFN-IND-1 contains a 367-bp EcoRI restriction fragment of exon 2 of the gene (Akai and Larner, 1989 ) subcloned into pGEMI. The size of the protected fragment for pIFN-IND-1 is 367 bp. A 1400-bp PSTI fragment of rat GAPDH (Piechaczyk et al., 1984) was subcloned into pGEMI. The insert was linearized with Sau 3A; the size of the protected fragment is 320 bp. To determine the relative rate of transcription of ISG-54K, 3P-labeled antisense RNA probes containing 250 bp upstream of the cap site of the gene and 1 18 bp downstream were hybridized to 10 ,g of total cellular RNA. The protected 1 1 8-bp fragment represents unprocessed nuclear RNA (Levy et al., 1986) . (The processed 78-bp product representing exon 1 was electrophoresed off the gels shown in Figure 2 ).
Solution hybridization and RNase mapping
Five to 10 qg of total cellular RNA were hybridized with 1 05 cpm of 32P-labeled antisense RNA probe in 800/o (v/v) formamide, 40 mM piperazine-N,/-bis[2-ethanesulfonic acid] (PIPES), 0.4 M NaCI, and 1 mM EDTA at 560C for 16-20 h, and the protected RNA was analyzed essentially as described (Akai and Larner, 1989) , except that Ti RNase was used instead of T2 RNase. Ti RNase (130 U) was added in a 330-,ul digestion buffer containing 200 mM NaCI and 20 mM tris(hydroxymethyl)aminomethane (Tris), pH 7.4. Samples were incubated 1 h at 370C, and protected RNA was extracted with phenol:chloroform; precipitated by the addition of ethanol; evaporated; resuspended in the loading buffer containing 94% (v/v) formamide, 10 mM EDTA, 0.05Yo (w/v) xylene cyanol, and 0.05% (w/v) bromophenol blue; and electrophoresed through 5Yo (w/v) acrylamide gel containing 42% (w/v) urea, 40 mM Tris, 40 mM boric acid, and 1 mM EDTA. The gels were exposed to X-ray film at -700C with the use of an intensifying screen. The relative rates of transcription shown in Figures 3 and 4 were determined by densitometry of the 1 1 8-bp RNase-resistant fragment (see Figure 2). The relative intensity of the protected fragment was normalized to the 320-bp protected fragment corresponding to GAPDH, which was assayed simultaneously in the same hybridizations. In all other experiments, phorbol ester inhibition of IFN-induced ISG-54K RNA expression was quantitated by densitometry using GAPDH as an internal control; the results are stated in the text. In general, phorbol esters inhibited IFN-induced ISG-54K expression from 85%o to >99% in human fibroblasts.
